secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2022-03-29T23:59:59+00:00
Accession:  0001731122-22-000565
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Carl Sandler resigns from Enochian Biosciences board effective March 25, 2022
-----------------------------------------------------------------------------

- Carl Sandler resigned as board member on March 25, 2022 to focus on other business ventures.
- Resignation effective immediately; not due to any disagreement with company operations, policies, or practices.
- No replacement named; CEO Mark R. Dybul signed the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112222000565/0001731122-22-000565-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112222000565/e3650_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-22-000565

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer